Articles

  • 21 hours ago | forbes.com | Russell Flannery

    Red Star Macalline Group Corp., the operator of one of China’s largest chains of furniture and home decoration malls, said late Monday founder and executive director Che Jianxing has been detained and is under investigation. Red Star “was informed” that Che, a former billionaire, “is under an official investigation and detained by the Yunnan Provincial Supervisory Committee,” according to a company filing at the Hong Kong Stock Exchange.

  • 1 day ago | forbes.com | Russell Flannery

    A top American group that advances U.S.-China business today lauded a bilateral agreement announced over the weekend to lower tariffs which have wreaked havoc on trade between the world’s two biggest economies.

  • 1 week ago | forbes.com | Russell Flannery

    U.S.-China trade tensions that have disrupted business between the two sides didn’t derail a scheduled cultural open house at the Chinese embassy in Washington, D.C. over the weekend. According to embassy figures, more than 10,000 visitors waited in a line that wrapped around the block where the country’s main diplomatic offices in the U.S. are located for a tour that focused on inland Gansu province.

  • 2 weeks ago | forbes.com | Russell Flannery

    Chinese luxury brand “naked,” jointly owned by the naked Group and online travel giant Trip.com, last week launched a new luxury getaway in time for the country’s upcoming long May 1-5 holiday travel boom. naked Home Grand Ginkgo Valley · Suizhou is located in China’s millennium-old ginkgo forest.

  • 2 weeks ago | forbes.com | Russell Flannery

    The U.S. Food and Drug Administration this week granted permission for the use of a new cancer drug from China despite high-profile strains in ties between the two countries. Akeso said on Thursday it has received approval for treatments with penpulimab-kcqx, which is used in the fight against nasopharyngeal cancer, or NPC. In a separate announcement, the drug co-developer Sino Biopharmaceutical also noted FDA approval of the marketing of penpulimab.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
2K
Tweets
2K
DMs Open
No
Russell Flannery
Russell Flannery @rflannerychina
5 May 25

Wudn't it be better all-around if the U.S. movie industry focused on creating content that appeals to larger audiences?... $PARA $DIS #Hollywood $WBD https://t.co/7GKviJ8gZK

Russell Flannery
Russell Flannery @rflannerychina
28 Jan 25

That the Smithfield listing happened at all in today's geopolitical environment has to be a success for Chinese billionaire Wan Long #China #Smithfield #billionaires $SFD #WHGroup #Nasdaq https://t.co/19kTSw1evI

Russell Flannery
Russell Flannery @rflannerychina
17 Dec 24

Worth a listen: Eric Schmidt on AI, U.S. vs. China AI competition #DeepSeek #China #AI @ericschmidt https://t.co/dTHRsrbfgU